Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01096550 · ClinicalTrials.gov registry record · NA
Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans
A NA study of Drug Dependence, sponsored by Friends Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 319
- Enrollment target
- 1
- Study location
NCT01096550: Completed NA study of Drug Dependence, sponsored by Friends Research Institute.
NCT01096550 is a NA study of Drug Dependence that has completed, run by Friends Research Institute. The registered enrollment target is 319 participants, above the 270-participant average among 9 other Drug Dependence trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01096550, a NA study of Drug Dependence, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 319 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of different levels of counseling (intensive outpatient versus standard outpatient) on treatment outcomes for African American adult patients receiving buprenorphine in 2 formerly "drug-free" programs.
Conditions Studied
Interventions
- BEHAVIORAL Outpatient
- BEHAVIORAL Intensive Outpatient
Study Locations (1)
Maryland
- Friends Research Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 319 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT01096550 record still lists
NCT01096550 is an interventional study that assigns participants to a tested intervention. The registered 319 participants enrollment target is mid-sized for trials with a published cap, above the 270-participant average among 9 other Drug Dependence trials with a reported enrollment target (18% higher).
The record links to 1 condition, with Drug Dependence appearing as the primary indexed condition, and to 2 interventions - of which Outpatient is the first listed.
NCT01096550 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01096550 about?
NCT01096550 is a clinical study titled "Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans". The purpose of this study is to compare the effectiveness of different levels of counseling (intensive outpatient versus standard outpatient) on treatment outcomes for African American adult patients receiving buprenorphine in 2 formerly "drug-free" programs.
What is the current status of trial NCT01096550?
This trial is currently completed. It is a NA study. The enrollment target is 319 participants. The study started on 2010-03. Estimated completion is 2011-10.
What conditions does trial NCT01096550 study?
This clinical trial studies the following conditions: Drug Dependence.
What interventions are being tested in trial NCT01096550?
The interventions under investigation include: Outpatient (BEHAVIORAL), Intensive Outpatient (BEHAVIORAL).
Who is sponsoring clinical trial NCT01096550?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01096550 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01096550's enrollment target sits among peer trials
319 4th of 9 higher than 6 of 9 other Drug Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Drug Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CB1R in Synthetic Psychoactive Cannabinoids
ACTIVE NOT RECRUITING · NA
-
Integrated Treatment of OEF/OIF Veterans With PTSD & Substance Use Disorders
COMPLETED · NA
-
Innovative Digital Therapeutic for Smoking Cessation
COMPLETED · NA
-
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
COMPLETED · Phase 3
-
Drug Discrimination in Methadone-Maintained Humans Study 3
COMPLETED · Phase 1
-
The Effect of Fetal Gender on Maternal Substance Abuse Treatment
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05377996 · 319 participants · Phase 1
A Study of XMT-1660 in Participants With Solid Tumors
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia